✦ LIBER ✦

Assessing the risk of breast cancer recurrence in node-positive patients with Oncotype DX and Adjuvant!

✍ Scribed by Jame Abraham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P197 Oncotype Dx; St. Gallen risk group

✍ L. Leitzin; N. Sikorsky; M. Leviov; E. Grikstass; M. Steiner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Does oncotype DX recurrence score affect

✍ Juhi Asad; Allyson F. Jacobson; Alison Estabrook; Sharon Rosenbaum Smith; Susan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Impact of Oncotype DX on Treatment Decis

✍ Biroschak, Julianne R.; Schwartz, Gordon F.; Palazzo, Juan P.; Toll, Adam D.; Br 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

P206 German multicentre decision impact

✍ J.-U. Blohmer; T. Kühn; M. Rezai; S. Kümmel; M. Warm; H. Eggemann; K. Friedrichs 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Comparison of efficacy of 95-gene and 21

✍ Yasuto Naoi,Kazuki Kishi,Ryo Tsunashima… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 323 KB

High recurrence risk and use of adjuvant

✍ Akiyo Horio; Takashi Fujita; Hironori Hayashi; Masaya Hattori; Naoto Kondou; Mai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 505 KB